BeStock  
Stocks › Biotechnology › PHVS

Pharvaris PHVS

US equityMarket cap rank #2618Biotechnology
$31.28 −$0.38 (-1.20%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $31.28 0.00%
Open$31.41
Prev close$31.66
Day range$30.43 – $31.99
Volume464.0K
Market cap$2.21B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

PHVS at a glance

Shares of Pharvaris are down 1.20% at $31.28. The company is worth $2.21B, number 2618 out of 3753 on our list.

Over a full year the shares have ranged across $23.15 to $43.25, which puts the current price roughly 40% of the way up that band. Holders are ahead 26.0% over twelve months, but down 16.2% across the last three months.

On the chart it has slipped under both the 50-day ($32.70) and 200-day ($31.46) moving averages; RSI is 41, and the last 30 sessions moved at roughly 45% annualized volatility.

Revenue for the quarter ended Sep 2026 was €0.00, and a net loss of €47.41M.

11 analysts follow the stock and the average call is "buy". The mean target, $62.45, sits 99.6% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$31.50 / $32.50
Average price today$31.36
Volume464.0KAvg (90d) 685.9K
Turnover$14.55M
Turnover rate0.84%of shares outstanding
Volume ratio1.65vs. recent average pace
Day amplitude4.93%
Market cap$2.21B
Float market cap$1.72B
Shares outstanding55.10M
EPS (TTM)-$3.26
P/B7.62
Book value / share$4.11
Net profit (TTM)-$230.57M
Net assets$290.60M
30-day volatility45.1%annualized
Avg daily range (ATR)5.36%of price, 14 days
Max drawdown (1y)-28.6%-19.5% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

B
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

D
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

11 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 49.9 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability3.1
Momentum54.4
Financial health76.0
Analyst view90.7

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$62.45+99.6% vs. current price
Consensus ratingBuy11 analysts covering
Morningstar fair value$36.43Price is below fair value

Wall Street’s average 12-month target is $62.45, 99.6% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $36.43, so shares trade 14.1% below that estimate. On earnings multiple, it sits in the 10th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-1.2%
1 week
-6.2%
1 month
+2.0%
3 months
-16.2%
6 months
+5.4%
Year to date
+12.7%
1 year
+26.0%
Day range
$30.43$31.99
52-week range
$23.15$43.25

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-5.5%Bearish
Price vs 50-day average-4.3%Bearish
Price vs 200-day average-0.6%Bearish
50-day vs 200-day50d above 200dBullish
RSI (14)40.8Bearish
MACD (12,26,9)-0.13Bearish
Bollinger band position10%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How PHVS ranks on BeStock

Market value#2607 of 3734
Closeness to 52-week high#2002 of 3724
Dollar volume today#2200 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

PHVS is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on PHVS.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on PHVS

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

PHVS stock: common questions

How is Pharvaris stock doing today?

$31.28 is the latest print for PHVS, a move of -1.20% against yesterday's close of $31.66. Today's low and high so far: $30.43 and $31.99.

What is PHVS worth in total?

Equity value comes to $2.21B at the current price. By that measure it is number 2618 of the 3753 names in our coverage.

Is PHVS near its 52-week high or low?

The year's floor is $23.15 and the ceiling $43.25. Shares are 27.7% away from that ceiling.

Does Pharvaris pay a dividend?

Our data shows no dividend paid by Pharvaris over the trailing twelve months.

Is PHVS rated a buy by Wall Street?

Of 11 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $62.45, with the most cautious at $44.00 and the most optimistic at $79.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on PHVS.

Sign in to join the discussion.

Scroll to Top